Toll样受体介导的抗乙型肝炎病毒的固有免疫

高珍; 张伦理

Toll样受体介导的抗乙型肝炎病毒的固有免疫

高珍,
张伦理

南昌大学第一附属医院

详细信息

中图分类号: R512.62
计量
- 文章访问数: 3354
- HTML全文浏览量: 14
- PDF下载量: 850
- 被引次数: 0
出版历程
- 出版日期: 2011-06-20

Toll like receptors mediated innate immune responses against HBV infection

摘要

摘要: 在抗感染免疫过程中,特别是病毒感染早期,固有免疫应答具有重要意义。固有免疫系统发挥防御作用的关键是对病原体的识别,Toll样受体(TLRs)作为固有免疫的重要组分之一,通过配体识别、信号转导、免疫分子活化等环节启动固有免疫并调节获得性免疫。本文就近年来TLRs介导的固有免疫抗乙型肝炎病毒感染的作用和相关的免疫调节机制进行综述。
- Toll样受体 /
- 肝炎病毒,乙型
Abstract: In the process of immunity against infection, particularly in early infection, innate immune response plays an important role.The key defensive role of innate immune system is to recognize pathogens, through Toll-like receptors, which act as an important part of innate immunity, by trigerring the innate immune response and regulating adaptive immune response through series of steps, such as ligand recognition, signal transduction, molecular activation, et al.This paper mainly review the last advances of TLRs mediated innate immune response against HBV infection, and discuss related immune regulatory mechanisms.
- Toll-like receptors /
- hepatitis B virus

HTML全文

参考文献(31)

[1]Lok AS, McMahon BJ.Chronic hepatitis B[J].Hepatology, 2007, 45 (2) :507-539.

[2]Dienstag JL.Hepatitis B virus infection[J].N Engl J Med, 2008, 359 (14) :1486-1500.

[3]Liaw YF, Chu CM.Hepatitis B virus infection[J].Lancet, 2009, 373 (14) :582-592.

[4]Bertoletti A, Gehring AJ.The immune reponse during hepatitisB virus infection[J].J Gen Virol, 2006, 87 (7) :1439-1449.

[5]Wang FS, Zhang Z.Host immunity influences diseaseprogression and antiviral efficacy in humans infected withhepatitis B virus[J].Hepatol, 2009, 3 (5) :499-512.

[6]Boonstra A, Woltman AM, Janssen HL.Immunology of hepatitisB and hepatitis C virus infection[J].Best Pract Res ClinGastroenterol, 2008, 22 (6) :1049-1061.

[7]Szabo G, Mandrekar P, Dolganiuc A.Innate immune response andhepatic inflammation[J].Semin Liver Dis, 2007, 27 (4) :339-350.

[8]Tahar MS, Touqui L, Chignard M.Innate immunity andinflammation-two facets of the same anti-infectious reaction[J].Clin Exp Immuno, 2009, 156 (3) :194-198.

[9]Mogensen TH.Pathogen recognition and inflammatorysignaling in innate immune defense[J].Clin Microbiol Rev, 2009, 22 (2) :240-273.

[10]Xagorari A, Chlichlia K.Toll-like receptors and viruses:inductionof innate antiviral immune responses[J].Open Microbiol J, 2008, 2 (8) :49-59.

[11]Lund J, Sato A, Akira S, et al.Toll-like receptor 9-mediatedrecognition of herpes simplex virus-2 by plasmacytoid dendriticcells[J].J Exp Med, 2003, 198 (3) :513-520.

[12]Takaoka A, Yanai H.Interferon signaling network in innatedefence[J].Cell Microbiol, 2006, 8 (6) :907-922.

[13]Kawai T, Akira S.Antiviral signaling through pattern recognitionreceptors[J].J Biochem, 2007, 141 (2) :137-145.

[14]Sadler AJ, Williams BR.Interferon inducible antiviral effectors[J].Nat Rev Immunol, 2008, 8 (7) :559-568.

[15]Isogawa M, Robek MD, Furuichi Y, et al.Toll-like receptorsignaling inhibits hepatitis B virus replication in vivo[J].J Virol, 2005, 79 (11) :7269-7272.

[16]刘华, 陈志翱, 成玉明, 等.乙型肝炎病毒表面抗原抑制TLR2和TLR4的激活[J].微生物与感染, 2008, 2 (3) :84-89.

[17]Riordan SM, Skinner N, Kurtovic J, et al.Reduced expression oftoll-like receptor 2 on peripheral monocytes in patients with chronichepatitis B[J].Clin Vaccine Immunol, 2006, 13 (8) :972-974.

[18]Chen Z, Cheng Y, Xu YF, et al.Expression profiles andfunction of Toll-like receptors 2 and 4 in peripheral bloodmononuclear cells of chronic hepatitis B patients[J].CliniImmunol, 2008, 128 (3) :400-408.

[19]Visvanathan K, Skinner NA, Thompson AJ, et al.Regulation ofToll-like receptor-2 expression in chronic hepatitis B by theprecore protein[J].Hepatology, 2007, 45 (1) :102-110.

[20]Zhang Y, Lian JQ, Huang CX, et al.overexpression of Toll-like receptor 2/4 on moncytes modulates the activities ofCD4+CD25+regulatory T cells in chronic hepatitis B virusinfection[J].Virology, 2010, 397 (1) :34-42.

[21]Ratnam D, Visvanathan K.New concepts in theimmunopathogenesis of chronic hepatitis B:the importanceof the innate immune reponse[J].Hepatol Int, 2008, 2 (Suppl1) :s12-s18.

[22]Xu N, Yao HP, Sun Z, et al.Toll-like receptor 7 and 9expression in peripheral blood mononuclear cells frompatients with chronic hepatitis B and related hepatocellularcarcinoma[J].Acta Pharmacol Sin, 2008, 29 (2) :239-244.

[23]Xie Q, Shen HC, Jia NN, et al.Patients with chronic hepatitisB infection display deficiency of plasmacytoid dendritic cellswith reduced express of TLR9[J].Microbes infect, 2009, 11 (2) :515-521.

[24]Chen Y, Wei H, Gao B, et al.Activation and function ofhepatic NK cells in hepatitis B infection:an underinvestigatedinnate immuner response[J].J Viral Hepat, 2005, 12 (1) :38-45.

[25]Kondo Y, Ueno Y, Shimosegawa, et al.Immunopathpgenesisof hepatitis B persistent infection:implication forimmunotherapeutic strategies[J].Clin J gastroenterology, 2009, 2 (2) :71-79.

[26]Paturel CA, Trinchieri G.Production of type Iinterferons:plasmacytoid dendritic cells and beyond[J].JExp Med, 2005, 202 (4) :461-465.

[27]Wang K, Fan X, Fan Y, et al.Study on the fuction ofcirculating plasmacytoid dendritic cells in the immunoactivephase of patients with chronic genotype B and C HBVinfection[J].J Viral Hepat, 2007, 14 (4) :276-282.

[28]Gabriele L, Ozato K.The role of the interferon regulatoryfactor (IRF) family in dendritic cell development and fuction[J].Cytokine Growth Factor Rev, 2007, 18 (5) :503-510.

[29]Honda K, Yanai H, Mizutani T, et al.Role of a transductional-transcriptional processor complex involving MyD88 andIRF-7 in Toll-like receptor signaling[J].Proc Natl Acad SciUSA, 2004, 101 (43) :15416-15421.

[30]Xu YF, Hu YW, Shi BS, et al.HBsAg inhibits TLR9-mediatedactivation and IFN-αproduction in plamacytoid dendriticcells[J].Mol Immunol, 2009, 46 (13) :2640-2646.

[31]Moynagh PN.TLR signalling and activation of IRFs:revisitingold friends from the NF-kappaB pathway[J].TrendsImmunol, 2005, 26 (9) :469-476.

施引文献

资源附件(0)

访问统计